The intracellular fate of non-viral DNA carriers

Cellular and Molecular Biology Letters

Volumn 5, Issue 3, 2000, Pages 295-313

  Langner, M ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Cationic Lipids; Non Viral Vectors; Transfection

Indexed keywords

ARTICLE; CELL FUNCTION; CELL MEMBRANE; CYTOSOL; GENE TARGETING; GENE THERAPY; GENETIC DISORDER; GENETIC ENGINEERING; GENETIC TRANSFECTION; IMMUNE SYSTEM; MOLECULAR BIOLOGY;

EID: 0033766794     PISSN: 14258153     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (119)

1. Gene transfer technology in therapy: Current applications and future goals
2. Cationic liposome-mediated transfection
3. Application of lipids and plasmid design for gene delivery to mammalian cells
4. Gene-delivery systems using catioic polymers
5. T-cell activation and the dynamic world of rafts
6. Anioic phospholipids are determinants of membrane protein topology
7. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
8. Lipid microdomains in cell surface membranes
9. Cell surface organization by the membrane skeleton
10. Coated vesicles: A diversity of form and function
11. Intracellular trafficking of phospholipids: Import of phosphatidylserine into mitochondria
12. Topology of glycosphingolipid degradation
13. The electrostatics of lipid surfaces
14. On the principle of functional ordering in biological membranes
15. Membrane flow, lipid sorting and cell polarity in HepG2 cells: Role of a subapical compartment
16. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function
17. Sphingomyelin-cholesterol interactions in biological and model membranes
18. Intracellular delivery of lipopolysaccharide during DNA transfection activates a lipid A - Dependent cell death response that can be prevented by polymyxin B
19. Antisense oligonucleotides: Strategies for delivery
20. Cationic lipids (lipofectamine) and disturbance of cellular cholesterol and sphingomyelin distribution modulates gamma-secretase activity within amyloid precursos protein in vitro
21. Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: A word of caution
22. DNA bending by small, mobile multivalent cations
23. DNA condensation by multivalent cations
24. A symmetrical and biodegradable cationic lipid. Synthesis and application for efficient gene transfection
25. Novel cationic liposomes for DNA-transfection with high afficiency and low toxicity
26. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery
27. Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer
28. Novel cationic lipids for gene delivery and gene therapy
29. Lipitoids-novel cationic lipids for cellular delivery of plasmid DNA in vitro
30. Phosphonolipids as non-viral vectors for gene therapy
31. Guanidinium-cholesterol cationic lipids: Novel reagents for gene transfection and perspectives for gene therapy
32. Guanidinium-cholesterol cationic lipids: Efficient vectors for the transfection of eukariotic cells
33. Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability
34. Novel cationic lipide peptide dendrimer vectors in vitro gene delivery
35. Branched cationic peptides for gene delivery: Role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes
36. Efficient adventital gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes
37. Water-soluble polyion complex associates of DNA and poly(ethyleneglycol)-poly(l-lysine) block copolymer
38. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly)L-lysine) block copolymer
39. Virus-sized self-assembling lamellar complexes between DNA and cationic micelles promote gene transfer
40. Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides
41. Cationic liposomes for gene therapy
42. Biophysical characterization of cationic lipid:DNA complexes
43. The role of helper lipids in cationic liposome-mediated gene transfer
44. Influence of the DNA complexation medium on the transfection efficiency of lipospermine/DNA particles
45. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection
46. Self-assembling DNA-lipid particles for gene transfer
47. Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: An alternative to cationic liposome/DNA aggregates
48. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA
49. Physicochemical characterization and purification of cationic lipoplexes
50. Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes
51. Phosphatidylethanolamine liposomes: Drug delivery, gene transfer and immunodiagnostic applications
52. Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo
53. New cationic lipid formulations for gene transfer
54. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration
55. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum
56. Intracellular accumulation of secreted proteoglycans inhibits cationic lipid-mediated gene transfer
57. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides
58. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
59. Pharmacokinetics and tissue distribution in monkeys of an antisense oligonucleotide inhibitor of Ha-Ras encapsulated in stealth liposomes
60. Stericaly stabilized liposomes: A hypothesis on the molecular origin of the extended circulation time
61. Surface-modified liposomes: Assessment and characterization for increased stability and prolonged blood circulation
62. Oligodeoxyribonucleotide uptake in primary human hematopietic cells is enhanced cationic lipids and depends on the hematopoietic cell subset
63. Targeted drug delivery
64. Targetable polymeric drugs
65. Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes)
66. Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells
67. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes
68. Enhancement of transfection efficiency using ligand-modified lipid vesicles
69. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferin or fusigenic peptides
70. Inductive electron-withdrawal from ammonium ion headgroups of cationic lipids and the influence on DNA transfection
71. Poly(ethylene glycol)-lipid conjugates inhibit phospholipase C-induced lipid hydrolysis, liposome aggregation and fusion through independent mechanisms
72. Calcium ions as efficient cofactor of polycation-mediated gene transfer
73. Temperature- and pH-controlled fusion between complex lipid membranes. Examples with the diacylphosphatidylcholine/fatty acid mixed liposomes
74. Peptides and membrane fusion: Towards an understanding of the molecular mechanism of protein-induced fusion
75. To fuse or not to fuse: The effects of electrostatic interactions, hydrophobic forces, and structural amphiphilicity on protein-mediated membrane destabilization
76. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides
77. HVJ (Sendai virus)-cationic liposomes: A novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium
78. Application of membrane-active peptides for nonviral gene delivery
79. 2H NMR
80. Lipid domains in biological-membranes
81. Melittin-induced leakage from phosphatidylcholine vesicles is modulated by cholesterol: A property used for membrane targeting
82. Influenza viruses select ordered lipid domains during budding from the plasma membrane
83. Membrane fusion plays an important role in gene transfection mediated by cationic liposomes
84. Dynamin GTPase, a force-generating molecular switch
85. Dynamin GTPase is stimulated by crosslinking through the C-terminal proline-rich domain
86. Subcellular trafficking of the cytoplasmic expression system
87. In vitro fusion of endocytic vesicles: Effects of reagents that alter endosomal pH
88. Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency
89. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
90. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids
91. Interaction of cationic lipid vesicles with negatively chargedphospholipid vesicles and biological membranes
92. Lysosome-disrupting peptide increases the efficiency of In-vivo gene transfer by liposome-encapsulated DNA
93. Cationic lipids destabilize lysosomal membrane in vitro
94. Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation
95. Synthesis of acid-labile diplasmenyl lipids for drug and gene delivery applications
96. Acid-catalized plasmenylcholine hydrolysis and its effect on bilayer permeability: A quantitative study
97. Cytosolic drug delivery using pH- and light-sensitive liposomes
98. Fusion of cationic liposomes with mammalian cells occurs after endocytosis
99. The influenza virus hempgglutinin: A model protein in the study of membrane fusion
100. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery
101. High efficiency transformation by direct microinjection of DNA into mammalian cells
102. Metabolic instability of plasmid DNA in the cytosol: A potential barrier to gene transfer
103. On the mechanism of DNA transfection: Efficient gene transfer without viruses
104. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
105. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery
106. Analysis of cationic liposome-mediated interactions of plasmid DNA with murine and human melanoma cells in vitro
107. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells
108. Lipid-mediated transfection of normal adult human hepatocytes in primary culture
109. Cationic lipid-mediated transfection of cells in culture requires mitotic activity
110. Retrovirus budding may constitute a port of entry for drug carriers
111. Development and characterization of cationic liposomes conjugated with HVJ (Sendai Virus): Reciprocal effect of cationic lipid for in vivo and in vitro gene transfer
112. Lipid signaling and cell responses at the nuclear level
113. Endocytic sorting of lipid analogs differing solely in the chemistry of their hydrophobic tails
114. Trafficing of glycosphingolipids in eukaryotic cells: Sorting and recycling of lipids
115. Lateral organization of membrane lipids. The superlattice view
116. Biological effects and cellular uptake of c-myx antisense oligonucleotides and their cationic liposome complexes
117. Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice
118. Immunoliposomes for cancer treatment
119. Development of targeted delivery systems for nucleic acid drug